Literature DB >> 8472578

Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone.

D Gommers1, C Vilstrup, J A Bos, A Larsson, O Werner, E Hannappel, B Lachmann.   

Abstract

OBJECTIVE: To study the immediate effects of exogenous surfactant therapy on blood gases, lung volumes, and lung mechanics in adult rabbits with experimentally induced respiratory distress syndrome.
DESIGN: Prospective randomized, controlled study.
SETTING: Laboratory and animal facility of a large university.
SUBJECTS: Twelve adult New Zealand white rabbits.
INTERVENTIONS: Respiratory failure was induced by repeated bilateral whole-lung lavage with saline (30 mL/kg body weight). After the last lavage, the animals were randomly assigned to two groups. Group 1 received surfactant (120 mg/kg body weight) that was suspended in a 0.6% sodium chloride solution. Group 2 received comparable volumes of the same hypotonic solution and served as controls.
MEASUREMENTS AND MAIN RESULTS: Before and after endotracheal surfactant instillation, blood gases and functional residual capacity were measured, and lung mechanics from tidal volumes and pressure-volume curves were calculated. Functional residual capacity was measured by a computerized, multiple-breath, washin-washout method using sulfur hexafluoride (SF6) as tracer gas. The pressure-volume curves were obtained by an occlusion technique originally described for measuring static breath-by-breath compliance. The technique was modified for present use and fully computerized. Within 60 mins after surfactant instillation, there were marked improvements in Pao2 (61 +/- 7 torr [8.2 +/- 0.9 kPa] to 470 +/- 47 torr [62.6 +/- 6.2 kPa]) and in functional residual capacity (7.6 +/- 1.4 to 17.7 +/- 1.6 mL/kg body weight) at unchanged ventilatory settings. The pressure-volume curves became steeper over time and the pressure-volume curves for total lung volume were restored to an almost normal state. Maximum compliance calculated from the pressure-volume curves increased by 92% but there was no significant change in dynamic compliance. In the control group, no improvements in any measured or calculated lung parameters were seen.
CONCLUSIONS: The findings indicate that during mechanical ventilation, the effects of surfactant therapy on lung mechanics are best characterized by changes in functional residual capacity and maximum compliance obtained from static pressure-volume curves and not by dynamic compliance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472578     DOI: 10.1097/00003246-199304000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  12 in total

1.  Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.

Authors:  A van't Veen; J W Mouton; D Gommers; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicle.

Authors:  A Van't Veen; D Gommers; S J Verbrugge; P Wollmer; J W Mouton; P P Kooij; B Lachmann
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Lower intra-abdominal pressure has no cardiopulmonary benefits during laparoscopic colorectal surgery: a double-blind, randomized controlled trial.

Authors:  Youn Joung Cho; Hyesun Paik; Seung-Yong Jeong; Ji Won Park; Woo Young Jo; Yunseok Jeon; Kook Hyun Lee; Jeong-Hwa Seo
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

4.  Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.

Authors:  A van 't Veen; D Gommers; J W Mouton; J A Kluytmans; E J Krijt; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Randomised controlled trial of respiratory system compliance measurements in mechanically ventilated neonates.

Authors:  B J Stenson; R M Glover; R A Wilkie; I A Laing; W O Tarnow-Mordi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

6.  Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.

Authors:  G Putz; C Hörmann; W Koller; G Schön
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

7.  Effect of positive end-expiratory pressure on inflammatory response in oleic acid-induced lung injury and whole-lung lavage-induced lung injury.

Authors:  Koichi Nakazawa; Kuninori Yokoyama; Naoko Yamakawa; Koshi Makita
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

8.  Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin.

Authors:  A van 't Veen; J W Mouton; D Gommers; J A Kluytmans; P Dekkers; B Lachmann
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

9.  The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.

Authors:  Johann M van Zyl; Johan Smith; Arthur Hawtrey
Journal:  Drug Des Devel Ther       Date:  2013-03-11       Impact factor: 4.162

10.  Identification of vitamin D sensitive pathways during lung development.

Authors:  Ling Chen; Richard Wilson; Ellen Bennett; Graeme R Zosky
Journal:  Respir Res       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.